Archive | Innovator’s Pitch Challenge RSS feed for this section

Last Chance to Apply for the Innovator’s Pitch Challenge

18 Feb

By Joey Wong, Investor Research Analyst, LSN

One of the most powerful features at Healthtech Partnering Week, March 15-19, is the Innovator’s Pitch Challenge. This is a valuable opportunity for fundraising CEOs to showcase their technologies to conference attendees and pitch live to a panel of active investors and industry experts. Each conference throughout the week will host its own Innovator’s Pitch Challenge to ensure best fit for sector and technology. Learn about each conference and determine the best fit for you!

Accepted companies will each be provided with a dedicated landing page on the conference’s Live Agenda, which will host a full-length pitch video, pitch deck, executive summary and any other supplementary materials that are submitted. Companies are also invited to participate in a live Q&A session, which will include a quick elevator pitch, followed by questions and insights from a panel of active investors and industry experts.

This is a valuable opportunity to not only boost exposure among all the conference attendees, but also connect and speak directly with active investors and industry experts in the space. If you are a fundraising CEO, you do not want to miss this opportunity!

The last day to apply for the Innovator’s Pitch Challenge is this Friday, February 19. Be sure to submit your applications before then!

Apply for RESI IPC
March 15 – 17
Apply for 4D Meets AI IPC
March 18 – 19
Apply for LHI IPC
March 18 – 19

Innovator’s Pitch Challenge Applications Open at LSN Healthtech Partnering Week

21 Jan

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireLife Science Nation (LSN)’s Healthtech Partnering Week serves as a vehicle for early-stage fundraising within life science and healthcare with many valuable features, including a match-based partnering system and hours of educational materials like entrepreneur bootcamps, branding workshops, and investor panels. However, one of the most powerful additions to the digital partnering space is the Innovator’s Pitch Challenge (IPC).

The IPC highlights exceptional early-stage companies and provides them the opportunity to pitch live to a panel of investor judges. Accepted companies submit pitching materials, including a pitch deck, executive summary, and a long-form pitch video that are sent to judges to review prior to live Q&A sessions. During the live session, each company will present a brief elevator pitch and participate in a Q&A from the judges and audience.

IPC applications are open until Friday, February 19th. Accepted applicants who sign up before Friday, January 29 will also save $100 on registration. Learn more about the IPC and how it can help boost your exposure and increase visibility to hundreds of investors and strategic partners!

Congratulations to Digital RESI January Innovator’s Pitch Challenge Winners!

14 Jan

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireOur 3-day Digital Redefining Early-Stage Investments (RESI) January Conference came to an end yesterday, and we are very excited to announce the Top 3 Winners of the Innovator’s Pitch Challenge (IPC). Each participating finalist company had a dedicated page featuring a short pitch, executive summary, and other supplementary materials available for viewing.

The Digital RESI January Live Agenda is open to registered attendees until February 13, so there’s still time to check out the Digital RESI January Live Agenda for virtual exhibit of innovative technologies across all life science & healthcare sectors!

The RESI Team would like to thank every IPC company for their virtual presentations, and the hard work to promote their technologies to our RESI community. The Top 3 winners will be awarded with free tickets to future RESI conferences. Congratulations to the Top 3 winners, and thanks to all for voting!

First Place: Concarlo Holdings

Concarlo Holdings, LLC is a precision medicine company focusing on unmet needs in oncology: developing therapeutics and diagnostics to extend the lives of cancer patients, beginning with women with metastatic breast cancer.

Check Concarlo Holdings’ Dedicated Page

 

Tied for Second Place: BCell Solutions

BCell Solutions, Inc., is a pre-clinical biopharmaceutical company commercializing a family of highly anti-inflammatory, small molecule peptides. Uses include treatment of chronic inflammation, acute/hyper-inflammation, and neuroinflammation. Our lead indication is kidney disease, supported by data from two animal models showing BCS Immunotherapy’s successful reversal of loss of kidney autoregulatory function, a key element of chronic kidney disease and renal failure.

Check BCell Solutions’ Dedicated Page

 

Tied for Second Place: Surgical Innovation Associates

Surgical Innovation Associates (SIA) is a Chicago-based medical device spin-out from Northwestern University with FDA 510(k) clearance, CE Mark, and rapidly growing sales for its first product, DuraSorb™ – a patented absorbable surgical mesh in the $1B+ general and reconstructive surgery market. In only a few months on the market, we have grown sales to >$100k/month at >80% gross profit margin. SIA is led by an industry-experienced management team and supported by a veteran Board of Directors as well as a reputable medical advisory board. Existing investors include ex-CEO’s and CFO’s of publicly traded medical device corporations (Baxter Healthcare, Baxalta, etc.), KOL surgeons from leading universities (Northwestern, NYU, Northshore) and respected angel groups from across the country (Harvard Business School Angels, Gopher Angels, Ann Arbor Angels). We’ve also received $2M of NCI SBIR grants with an opportunity for $4M of follow-on grant funding, providing investors with great leverage. We are now seeking a $10M Series B predominantly to fuel sales growth, with a target closing in Q1 2021.

Check Surgical Innovation Associates’ Dedicated Page

Longevity, Health & Innovation’s Innovator’s Pitch Challenge Finalists

14 Jan

By Rory McCann, Marketing Manager & Conference Producer, LSN

Hosting live pitch sessions has long been an important element in Life Science Nation (LSN)’s partnering conferences. These sessions help companies get their message out to investors who are a fit for their technology and stage of development. On behalf of conference organizers, LSN and Mary Furlong & Associates, we are pleased to highlight the following ten companies participating in the Innovator’s Pitch Challenge this week:

Longevity, Health & Innovation’s Innovator’s Pitch Challenge Finalists

Please click the logo to learn more about these companies, their teams, products, and technology. To learn more about the conference and Innovator’s Pitch Challenge, visit https://longevityhealthinnovation.com/pitch-challenge/.

Introducing the Innovator’s Pitch Challenge Finalists!

7 Jan

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireLife Science Nation (LSN)’s Inaugural Healthtech Partnering Week launches next week, which means the Innovator’s Pitch Challenge (IPC) is on! The IPC is an opportunity for early-stage, fundraising CEOs to pitch directly to a panel of judges, who follow up with a live Q&A session.

How does it work? The finalist companies deliver pitching materials, including a comprehensive slide deck, executive summary, and a long form pitch video to be hosted on a dedicated webpage the judges review prior to their live session. Sessions are split up by sectors and are designed to match up companies with investors actively seeking opportunities in their space. During the live session, companies deliver a brief short form pitch, which is then followed by a Q&A period with the judges.

Each event sees an incredible line up of early-stage companies delivering promising tech to advance life science and healthcare. LSN is proud to host this powerful meeting of the minds.

Innovator’s Pitch Challenge Finalists

Introducing the Digital RESI January Agenda

3 Dec

By Claire Jeong, Vice President of Investor Research, Asia BD, LSN

claireIntegral to Life Science Nation (LSN)’s Inaugural LSN Healthtech Partnering Week are the panel discussions featuring industry leaders and their insight into the early-stage fundraising ecosystem. The upcoming 3-day digital Redefining Early Stage Investments (RESI) Conference, January 11-13, kicks off Healthtech Partnering Week, and will feature 10 panels discussing various aspects of life science and healthcare fundraising.

All RESI panels are held live during the conference and feature active investors as panelists. From sector-focused panels like Early Stage Therapeutics and Medical Devices to panels focused on different types of investors like Family Offices and Corporate Venture Capital, there are relevant topics for all fundraising entrepreneurs and fellow investors who are seeking to gain valuable insights as they continue to make a mark in the life science industry.

We will also feature the Innovator’s Pitch Challenge (IPC) – virtual pitch sessions in which participating companies receive a dedicated webpage on our agenda and the opportunity to engage in a live Q&A session with investors and strategic partners interested in their products and services.

IPC companies pitch to a panel of judges featuring active investors and prominent industry experts and stay for a live Q&A. These sessions provide valuable insights and feedback to help companies improve on their capabilities.

If you are a fundraising CEO, you do not want to miss out on this opportunity. You can apply for free below!

Example of a Company’s Landing Page

We will also have a variety of workshops featuring topics relevant to the early-stage life science ecosystem. Though we cannot gather at San Francisco, as we have done for many consecutive years, we hope you can join us for RESI at Healthtech Partnering Week! RESI super early bird rates apply until December 4, so sign up today and save!

 

Boost Your Exposure at Healthtech Partnering Week – Apply for the Innovator’s Pitch Challenge (IPC)

19 Nov

By Claire Jeong, Vice President of Investor Research, Asia BD, LSN

claireWe are now accepting applications for the Innovator’s Pitch Challenge at Healthtech Partnering Week, taking place January 11-15, 2021.

The Innovator’s Pitch Challenge (IPC) is an opportunity for start-ups to boost their exposure and showcase their technology to conference attendees, particularly investors. Each company will be provided with a dedicated landing page on our virtual agenda, which will include their pitch video, slide deck, executive summary, and any other materials companies wish to feature on their page. In addition, the companies pitch to a panel of judges featuring active investors and prominent industry experts, and participate in a live Q&A. These sessions will provide valuable insights and feedback, as well as build connections between fundraising founders and potential strategic partners.

If you are a fundraising CEO, you do not want to miss out on this opportunity.

Example of a Company’s Landing Page